Rappler
Duterte sees Philippines back to ‘normal’ by 2023
President Rodrigo Duterte stated that the Philippines might not return to normal until the first or second quarter of 2023 due to the ongoing COVID-19 pandemic.
The country received its initial shipment of 600,000 vaccine doses from China on Sunday, and the immunization program will be expedited.
The first COVID-19 vaccinations in the Philippines are scheduled to begin on Monday, March 1, 2021, in various Metro Manila hospitals.
Duterte projected that the Philippines could achieve herd immunity by early 2022, though he acknowledged having limited information on the subject.
He expressed concerns about the archipelagic nature of the Philippines and public hesitancy towards vaccines potentially hindering the achievement of herd immunity.
At least 525,600 doses of vaccines developed by AstraZeneca and Oxford University are expected to arrive in a week.
🤖
This story was generated by AI to help you understand the key points. For more detailed coverage, please see the news articles from trusted media outlets below.
News Sources
See how different news organizations are covering this story. Below are the original articles from various Philippine news sources that contributed to this summary.
The Philippines officially began its national COVID-19 vaccination program on March 1, 2021, administering the first Sinovac vaccine shots donated by China.
+3
Read more →
The Philippines' first batch of 600,000 Sinovac vaccines, donated by China, is scheduled to arrive on Sunday, February 28.
+1
Read more →
The Philippines commenced its COVID-19 vaccination program on March 1, 2021, using 600,000 Sinovac vaccine doses from China.
+3
Read more →
The Philippines is expecting doses of Pfizer and AstraZeneca COVID-19 vaccines through the COVAX facility.
+1
Read more →
Around 1.5 million doses of Sinovac's COVID-19 vaccine are anticipated to reach the Philippines, with an initial 600,000 doses donated by the Chinese government expected to arrive on Sunday, February 28.
+2
Read more →